About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSouthwestern U.S.
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
98
By Phase
PHASE2: 2PHASE1: 3
By Status
TERMINATED: 2COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06723171Lead Sponsor
Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis
PHASE2Not yet recruiting
20 participants
Started: Jun 30, 2025 · Completed: Apr 30, 2026
NCT02749708Collaborator
Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
PHASE1Terminated
13 participants
Started: Jan 30, 2017 · Completed: Aug 14, 2018
NCT02991651Lead Sponsor
Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
PHASE1Terminated
12 participants
Started: Dec 7, 2016 · Completed: May 9, 2025
NCT02438215Lead Sponsor
Study of IRX4204 for Treatment of Early Parkinson's Disease
PHASE1Completed
15 participants
Started: Aug 31, 2014 · Completed: May 31, 2015
NCT01540071Lead Sponsor
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
PHASE2Completed
38 participants
Started: Aug 31, 2011 · Completed: Dec 31, 2015
Locations (1)
Headquarters
Spring, TX, United States
Map
Loading map...